Microvast Holdings

Kodiak Sciences Inc

Atomera

Applied Optoelectronics

Sangamo Therapeutics

uniQure

Gevo

Codexis

Omeros

NETGEAR

Invesco Nasdaq Future Gen 200 ETF

QQQS tracks an equal-weighted index of 200 NASDAQ-listed stocks selected based on the value of their patent portfolios. The portfolio excludes the largest 200 stocks listed on NASDAQ.

Once stalwarts of the healthcare investing realm, biotechnology stocks and related ETFs have been laggards going back to 2021. That's a lengthy run of disappointment that's given some investors pause about embracing the space.

Biotechnology Rebound Might Boost QQQS

Small-cap stocks and the related exchange traded funds have moved in fits and starts this year. However, some market observers believe that with a recession unlikely, the asset class could be poised for a period of smoother upside.

This Small-Cap ETF Could Find Its Groove

For much of the first half of 2024, conversation saw a small number of stocks representing significant portions of the market's upside. In other words, market breadth was narrow and largely concentrated within a few mega-cap growth stocks.

Increasing Market Breadth Could Add to Small-Cap Rally

WisdomTree U.S. SmallCap Earnings Fund

Invesco KBW Regional Banking ETF

ALPS Medical Breakthroughs ETF

iShares US Small Cap Value Factor ETF

KBWR, QQQS, SVAL, EES and SBIO are included in this Analyst Blog.

The Zacks Analyst Blog KBWR, QQQS, SVAL, EES and SBIO

Small-cap stocks have staged a strong comeback buoyed by the Trump trade resurgence and the growing expectations of the Fed cutting rates in September.

5 Small-Cap ETFs at the Forefront of the Latest Rally

Small-cap stocks and related ETFs have spent considerable time tantalizing and tormenting investors. So it's understandable market participants may be leery of the asset class.

Is This Time Different? Small-Cap Stocks Finally Perking Up

Small-caps and the related ETFs continue vexing market participants. However, credible reasons remain as to why investors shouldn't be dismissive of this corner of the market.

Small-Caps Still Sluggish, But Opportunity Remains

Waiting on small-cap stocks and related ETFs to rally in earnest has, for many market participants, become an exercise in futility. Some encouraging news for smaller equities may have arrived last week in the form of the May reading of the Consumer Price Index (CPI).

Economic Data Could Ignite Small-Cap Rally

If there's one corner of the equity market that's trying investors' patience, it's small-caps. For more than a year now, analysts and other experts have opined that smaller stocks are due to rally.

Small-Caps Could Finally Be Ready for Some Upside

After a lengthy run of tantalizing and disappointing investors, small-cap stocks appear to be finally finding solid footing. For the month ending May 16, the Russell 2000 Index is higher by 7.74%, perhaps signaling smaller stocks are ready to deliver more sizable gains.

Ballast Emerging for Small-Cap Rally

Biotech stocks and the related exchange traded fund are in the midst of a lengthy run of disappointing investors. With the NASDAQ Biotechnology Index lower on a year-to-date basis, some market participants might be apt to continue eschewing this segment.

Biotech Rebound Could Boost This ETF

Is a rebound on the way? The Russell 2000 Index, one of the most widely followed gauges of small-cap stocks, is higher by 2.82% year-to-date, but that's still well above the pace set by the S&P 500, which is up 9.26%.

What It Will Take for Small-Caps to Rebound

Small-caps lagged last year. That's because a small number of mega-cap growth stocks accounted for the bulk of the broader market's returns.

Small-Cap Opportunity Set Still Looks Attractive

Broader gauges of small caps didn't do much to brag about through the first two months of 2024. However, some market observers believe the asset class is poised for a turnaround.

The Case for Small Caps Is Getting Interesting

Investors waiting on small-cap equities and related ETFs may be encountering a “Waiting for Godot” moment. That's because it feels like a while since small-caps have offered good reason to peer away from large-caps.

How Small-Cap Stocks, ETFs Can Get in Gear

Through one month and a day of trading action in 2024, the Russell 200 Index is off 2.63%. That's while large cap benchmarks are rallying.

Small Caps Can Still Deliver in 2024

The Russell 2000 Index is off 2.36% since the start of 2024, while the S&P 500 and other widely followed large-cap benchmarks have raced to new highs. That dichotomy has some market observers pondering the near-term fate of small-cap equities.

Small-Cap Stumble Could Be Buying Opportunity

For all the conjecture about small-caps stocks and related ETFs disappointing in 2023, the Russell 2000 Index still finished the year up 16.8%. Much of that upside was accrued in Q4 as the small-cap gauge surged 14%.

Plenty of Tailwinds for Small-Caps as 2024 Starts

Over the past month and the past 90 days, the Russell 2000 Index is higher by 12.07% and 8.49%, respectively. What's notable about those periods is that they include increased chatter that the Federal Reserve could be positioning for multiple interest rate cuts in 2024.

Rate Cuts Could Be Meaningful for Small-Cap ETFs

An oft-mentioned criticism of cap-weighted ETFs — mainly those dedicated to large-cap equities — is that when stocks rally, concentration risk in those funds can increase. 2023 has seen the “Magnificent Seven” group mega-cap growth stocks surge.

Concentrate on Small-Caps to Avoid Concentration Risk

For much of this year, the narrative surrounding small-cap equities and ETFs has been the extent to which that segment is lagging large-caps. That scenario has compelled many market participants to eschew the risks with smaller stocks and embrace the relative safety of larger fare.

Small-Cap Darkness Could Give Way to Dawn

Small-cap stocks and related ETFs have garnered plenty of attention in 2023 — much of it for the wrong reasons. Those include the group's laggard status relative to less volatile large-caps, sensitivity to rising interest rates, and vulnerabilities to economic contraction.

Small-Caps Could Surprise for the Better in 2024

Small-cap equities and related exchange traded funds have garnered plenty of attention this year. Much of that was derived by way of subpar performances and historically low multiples.

Small-Caps Could Prove Sturdy in Rocky Economy

Temptation isn't a valid investment thesis. Still, when it's supported by more credible factors, it can be hard to ignore and arguably useful.

Small-Caps Getting Too Tempting to Ignore

Pay enough attention to small-cap stocks and ETFs as of late and it's easier for even novice investors to identify at least two prominent points. First, there's a plethora of experts and market observers noting that small-caps are historically cheap today, and that assessment is accurate.

News for Invesco Nasdaq Future Gen 200 ETF ETF (QQQS)